{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:32Z","timestamp":1790975132527,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R43AI081394-1A2"],"award-info":[{"award-number":["1R43AI081394-1A2"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.081","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T22:17:19Z","timestamp":1510697839000},"page":"7121-7126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a synthetic Vi polysaccharide vaccine for typhoid fever"],"prefix":"10.1016","volume":"35","author":[{"given":"Yawei","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Finger-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.081_b0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMp078144","article-title":"Putting typhoid vaccination on the global health agenda","volume":"357","author":"DeRoeck","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.081_b0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Diseases"},{"key":"10.1016\/j.vaccine.2017.10.081_b0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"Lancet"},{"issue":"suppl. 3","key":"10.1016\/j.vaccine.2017.10.081_b0020","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1016\/j.vaccine.2015.03.102","article-title":"Antimicrobial resistance and management of invasive Salmonella disease","volume":"33","author":"Kariuki","year":"2015","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.10.081_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1099\/00222615-44-5-317","article-title":"Multi-drug resistant typhoid: a global problem","volume":"44","author":"Mirza","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.081_b0030","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1016\/j.vaccine.2005.07.111","article-title":"Vaccines against typhoid fever","volume":"24","author":"Guzman","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.081_b0035","series-title":"Vaccines","first-page":"781","article-title":"Typhoid fever vaccines","author":"Levine","year":"1999"},{"key":"10.1016\/j.vaccine.2017.10.081_b0040","unstructured":"Typhoid vaccines: WHO position paper. WHO Weekly Epidemiological Record: WHO, Geneva; 2008. p. 49\u201360."},{"key":"10.1016\/j.vaccine.2017.10.081_b0045","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1128\/JB.94.5.1406-1410.1967","article-title":"Physiochemical properties of the Vi antigen before and after mild alkaline hydrolysis","volume":"94","author":"Jarvis","year":"1967","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2017.10.081_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biologicals.2003.09.002","article-title":"Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by enzyme immunoassay","volume":"32","author":"Rijpkema","year":"2004","journal-title":"Biologicals: J Int Assoc Biol Standard"},{"key":"10.1016\/j.vaccine.2017.10.081_b0055","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/iai.29.2.539-544.1980","article-title":"Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants","volume":"29","author":"Szewczyk","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.081_b0060","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/IAI.59.12.4555-4561.1991","article-title":"Relation between structure and immunologic properties of the Vi capsular polysaccharide","volume":"59","author":"Szu","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.081_b0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.vaccine.2007.11.042","article-title":"Immune responses to polysaccharides: lessons from humans and mice","volume":"26","author":"Gonzalez-Fernandez","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.081_b0070","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1128\/JB.94.5.1411-1416.1967","article-title":"Physicochemical and biological properties of sonically treated Vi antigen","volume":"94","author":"Martin","year":"1967","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2017.10.081_b0075","unstructured":"Report of the Ad-hoc consultation on typhoid vaccine introduction and typhoid surveillance. WHO IVB\/12.02; 2012."},{"key":"10.1016\/j.vaccine.2017.10.081_b0080","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.081_b0085","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4161\/hv.19158","article-title":"Glycoconjugate vaccine strategies for protection against invasive Salmonella infections","volume":"8","author":"Simon","year":"2012","journal-title":"Human Vaccines Immunotherap"},{"key":"10.1016\/j.vaccine.2017.10.081_b0090","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1128\/IAI.62.10.4440-4444.1994","article-title":"Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.081_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0144-8617(90)90105-2","article-title":"Industrial pectins: sources, production, and applications","volume":"12","author":"May","year":"1990","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2017.10.081_b0100","series-title":"Food Polysaccharides and Their Applications","first-page":"287","article-title":"Pectins","author":"Voragne","year":"1995"},{"key":"10.1016\/j.vaccine.2017.10.081_b0105","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1128\/IAI.62.12.5545-5549.1994","article-title":"Synthesis and some immunologic properties of an O-acetyl pectin [poly(1\u2013>4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever","volume":"62","author":"Szu","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.10.081_b0110","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.vaccine.2016.01.064","article-title":"Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation","volume":"34","author":"Springer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.081_b0115","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.10.081_b0120","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1021\/jo01033a041","article-title":"Acetyl pectates and their reactivity with polyvalent metal ions","volume":"29","author":"Schweiger","year":"1964","journal-title":"J Organ Chem"},{"key":"10.1016\/j.vaccine.2017.10.081_b0125","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/ja01210a034","article-title":"The acylation of polyuronides with formamide as a dispersing agent","volume":"68","author":"Carson","year":"1946","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.vaccine.2017.10.081_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9258(18)56740-5","article-title":"The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application","volume":"180","author":"Hestrin","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.10.081_b0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0076-6879(03)01079-6","article-title":"Physical, chemical, antigenic, and immunologic characterization of polygalacturonan, its derivatives, and Vi antigen from Salmonella typhi","volume":"363","author":"Szu","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2017.10.081_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4142\/jvs.2002.3.2.67","article-title":"Efficacy of purified Vi polysaccharide typhoid vaccine","volume":"3","author":"Park","year":"2002","journal-title":"J Veterinary Sci"},{"key":"10.1016\/j.vaccine.2017.10.081_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.10.081_b0150","article-title":"From immunologically archaic to neoteric glycovaccines","volume":"5","author":"Cavallari","year":"2017"},{"key":"10.1016\/j.vaccine.2017.10.081_b0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2004.05.001","article-title":"Polysaccharide processing and presentation by the MHCII pathway","volume":"117","author":"Cobb","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2017.10.081_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-065X.2011.01075.x","article-title":"The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA","volume":"245","author":"Surana","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2017.10.081_b0165","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.vaccine.2011.12.046","article-title":"Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine","volume":"30","author":"An","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.081_b0170","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.vaccine.2011.07.013","article-title":"Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization","volume":"29","author":"Safari","year":"2011","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T09:26:36Z","timestamp":1659864396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17314895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.081","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a synthetic Vi polysaccharide vaccine for typhoid fever","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}